|
ZNF234 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50990331349021E-14 |
| Normal-vs-Stage2 |
3.34400000023827E-07 |
| Normal-vs-Stage3 |
4.65183447317941E-13 |
| Normal-vs-Stage4 |
2.71183075994941E-12 |
| Stage1-vs-Stage2 |
3.817600E-01 |
| Stage1-vs-Stage3 |
1.055630E-01 |
| Stage1-vs-Stage4 |
2.761800E-02 |
| Stage2-vs-Stage3 |
6.982000E-02 |
| Stage2-vs-Stage4 |
1.201520E-02 |
| Stage3-vs-Stage4 |
4.173200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.68313999999725E-05 |
| Normal-vs-Asian |
3.63420000004666E-06 |
| Caucasian-vs-AfricanAmerican |
4.679200E-01 |
| Caucasian-vs-Asian |
2.592100E-02 |
| AfricanAmerican-vs-Asian |
3.813000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53580481665472E-11 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
7.911800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.32658337040448E-12 |
| Normal-vs-Age(41-60Yrs) |
6.10622663543836E-15 |
| Normal-vs-Age(61-80Yrs) |
1.8588464101299E-12 |
| Normal-vs-Age(81-100Yrs) |
9.615700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.978200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.261600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.700000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.046800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.438800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.477000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.778800E-04 |
| Classical-VS-Follicular |
2.154200E-01 |
| Classical-VS-Other |
2.798600E-01 |
| Classical-VS-Normal |
1.76003656093826E-12 |
| Tall-VS-Follicular |
3.241900E-02 |
| Tall-VS-Other |
6.999600E-01 |
| Tall-VS-Normal |
6.41597885930878E-13 |
| Follicular-VS-Other |
5.198400E-01 |
| Follicular-VS-Normal |
2.53119747384289E-11 |
| Other-VS-Normal |
5.980700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.40962846634829E-13 |
| Normal-vs-N1 |
9.35019839332085E-11 |
| N0-vs-N1 |
2.537000E-01 |
|
|
